tiprankstipranks
Advertisement
Advertisement

RHHBY Stock Latest News

Roche announces agreement to acquire PathAI
The FlyRoche announces agreement to acquire PathAI
1d ago
CHRO
3 Best Vanguard Dividend ETFs for Stable Income in 2026
PremiumMarket News
3 Best Vanguard Dividend ETFs for Stable Income in 2026
1d ago
JPM
NVS
FDA blocked publication of studies showing Covid vaccine safe, NYT says
PremiumThe Fly
FDA blocked publication of studies showing Covid vaccine safe, NYT says
3d ago
AZN
BMY
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
PremiumThe Fly
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
3d ago
AZN
BMY
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
PremiumThe Fly
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
4d ago
CHRO
LCTX
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
PremiumThe FlyZealand Pharma, Roche to advance petrelintide for weight management to Phase 3
9d ago
CHRO
Novartis (NVS) CEO Warns Trump Drug Pricing Policy Could Hit Global Access as Earnings Slip
Premium
Market News
Novartis (NVS) CEO Warns Trump Drug Pricing Policy Could Hit Global Access as Earnings Slip
10d ago
AZN
NVS
Analyst Reiterates Buy on Roche, Maintains CHF 395 Price Target on Underappreciated Long-Term Pipeline Upside
Premium
Ratings
Analyst Reiterates Buy on Roche, Maintains CHF 395 Price Target on Underappreciated Long-Term Pipeline Upside
11d ago
CHRO
Genentech partners with comedian Damon Wayans for ‘All Eyes on DME’ campaign
PremiumThe Fly
Genentech partners with comedian Damon Wayans for ‘All Eyes on DME’ campaign
14d ago
CHRO
Roche upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe Fly
Roche upgraded to Equal Weight from Underweight at Morgan Stanley
14d ago
CHRO
Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
PremiumThe Fly
Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
15d ago
CHRO
Roche expects increase in group sales in mid single digit range for FY26
PremiumThe Fly
Roche expects increase in group sales in mid single digit range for FY26
15d ago
CHRO
Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
PremiumThe FlyGenentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
16d ago
CHRO
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
Premium
The Fly
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
17d ago
CHRO
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
Premium
The Fly
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
17d ago
CHRO
Roche’s Genentech reports FDA approval of sBLA for Gazyva
PremiumThe Fly
Roche’s Genentech reports FDA approval of sBLA for Gazyva
17d ago
CHRO
Trump names Erica Schwartz CDC Director
PremiumThe Fly
Trump names Erica Schwartz CDC Director
22d ago
AZN
BMY
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
PremiumThe Fly
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
22d ago
CHRO
SRPT
Trump Trade: White House launches space nuclear initiative
PremiumThe Fly
Trump Trade: White House launches space nuclear initiative
22d ago
F
GM
Drugmakers raised prices on hundreds of drugs, NBC News reports
PremiumThe FlyDrugmakers raised prices on hundreds of drugs, NBC News reports
22d ago
AZN
BMY
3 Best Vanguard Dividend ETFs for Reliable Passive Income in 2026
Premium
Market News
3 Best Vanguard Dividend ETFs for Reliable Passive Income in 2026
22d ago
COP
CVX
C4 Therapeutics expands long-term partnership with Roche
Premium
The Fly
C4 Therapeutics expands long-term partnership with Roche
29d ago
CCCC
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >